EPIXUnknownMicro-Cap
ESSA Pharma Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ESSA Pharma Inc. (EPIX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are EPIX insiders buying or selling?
ESSA Pharma Inc. insiders reported 11 open-market buys ($15.3M) and 14 sells ($13.7M) across 25 Form 4 filings — a net buying position of $1.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 7, 2025)
Total Form 4 filings
25
SEC EDGAR
Insider filers
6
Insider buys (11)
$15.3M
Insider sells (14)
$13.7M
Insider sentiment
Net buyingNet insider flow of $1.6M in net buying.
Recent EPIX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 7, 2025 | Mark N Lampert | 10% Owner | Sale | 156 | $1.88 | $292.95 |
| Nov 5, 2024 | V N Biotech Growth | 10% Owner | Sale | 7.9M | $1.53 | $12.0M |
| Oct 7, 2024 | Peter Virsik | Chief Operating Officer | Sale | 694 | $6.03 | $4.2K |
| Sep 9, 2024 | Peter Virsik | Chief Operating Officer | Sale | 694 | $6.00 | $4.2K |
| Sep 3, 2024 | Peter Virsik | Chief Operating Officer | Sale | 2.1K | $6.03 | $12.6K |
| May 6, 2024 | Peter Virsik | Chief Operating Officer | Sale | 694 | $6.95 | $4.8K |
| Apr 5, 2024 | Peter Virsik | Chief Operating Officer | Sale | 694 | $7.94 | $5.5K |
| Mar 5, 2024 | Peter Virsik | Chief Operating Officer | Sale | 694 | $8.98 | $6.2K |
| Feb 7, 2024 | Peter Virsik | Chief Operating Officer | Sale | 72.8K | $10.29 | $748.9K |
| Feb 6, 2024 | Peter Virsik | Chief Operating Officer | Sale | 1.2K | $9.58 | $11.4K |
| Jan 18, 2024 | Peter Virsik | Chief Operating Officer | Sale | 1.7K | $10.01 | $17.2K |
| Jan 9, 2024 | Peter Virsik | Chief Operating Officer | Sale | 699 | $6.11 | $4.3K |
| Dec 19, 2023 | David Ross Parkinson | Chief Executive Officer | Purchase | 9.2K | $2.30 | $21.2K |
| Nov 22, 2023 | Franklin M Berger | Director | Purchase | 23.3K | $5.73 | $133.3K |
| Nov 16, 2023 | Franklin M Berger | Director | Purchase | 76.5K | $5.49 | $419.7K |
| Jan 5, 2023 | David Ross Parkinson | Chief Executive Officer | Purchase | 24.4K | $2.42 | $59.0K |
| Jan 5, 2023 | Franklin M Berger | Director | Sale | 272.8K | $2.67 | $729.1K |
| Jan 5, 2023 | David S. Wood | Chief Financial Officer | Purchase | 8.3K | $2.60 | $21.6K |
| Oct 28, 2022 | V N Biotech Growth | 10% Owner | Purchase | 2.0M | $4.11 | $8.2M |
| Jul 20, 2022 | V N Biotech Growth | 10% Owner | Purchase | 300.0K | $3.16 | $946.7K |
| Jul 18, 2022 | V N Biotech Growth | 10% Owner | Purchase | 588.9K | $2.93 | $1.7M |
| Jul 5, 2022 | David Ross Parkinson | Chief Executive Officer | Purchase | 4.9K | $2.96 | $14.5K |
| Apr 28, 2022 | V N Biotech Growth | 10% Owner | Sale | 25.1K | $5.85 | $146.9K |
| Aug 20, 2021 | V N Biotech Growth | 10% Owner | Purchase | 250.0K | $8.88 | $2.2M |
| Mar 4, 2021 | Franklin M Berger | Director | Purchase | 57.0K | $27.00 | $1.5M |
Showing the 25 most recent of 25 Form 4 filings for ESSA Pharma Inc..
Most active EPIX insiders
- Peter Virsik10 filings
- V N Biotech Growth6 filings
- Franklin M Berger4 filings
- David Ross Parkinson3 filings
- David S. Wood1 filing
Ask anything about EPIX insider activity
Use Trabud's AI agent to query ESSA Pharma Inc.'s Form 4 history in plain English — "Show me EPIX CEO purchases this year" or compare it against any other ticker.
Open the AI agentEPIX insider trading FAQ
Are ESSA Pharma Inc. insiders buying or selling?
Across 25 SEC Form 4 filings, ESSA Pharma Inc. (EPIX) insiders reported 11 open-market purchases totaling $15.3M and 14 sales totaling $13.7M. That is a net buying position of $1.6M.
How many insiders trade EPIX stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ESSA Pharma Inc.. The most recent filing was accepted on Aug 7, 2025.
Where does Trabud get EPIX insider trading data?
All EPIX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.